Francis Bernard

Dr. Francis Bernard

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
FBFrancis Bernard
Francis Bernard
WBWilliam Barsan
William Barsan
RDRamon Diaz-Arrastia
Ramon Diaz-Arrastia
LMLisa H Merck
Lisa H Merck
SYSharon Yeatts
Sharon Yeatts
LSLori Shutter
Lori Shutter
Introduction: Management of traumatic brain injury (TBI) includes invasive monitoring to prevent secondary brain injuries. Intracranial pressure (ICP) monitor is the main measurement used to that intent but cerebral hypoxia can occur despite normal ICP. This study will assess whether the addition of a brain tissue oxygenation (PbtO 2 ) monitor prevents more secondary injuries that will translate into improved functional outcome. Methods and analysis: Multicentre, randomised, blinded-endpoint comparative effectiveness study enrolling 1094 patients with severe TBI monitored with both ICP and PbtO 2 . Patients will be randomised to medical management guided by ICP alone (treating team blinded to PbtO 2 values) or both ICP and PbtO 2 . Management is protocolised according to international guidelines in a tiered approach fashion to maintain ICP 20 mm Hg. ICP and PbtO 2 will be continuously recorded for a minimum of 5 days. The primary outcome measure is the Glasgow Outcome Scale-Extended performed at 180 (±30) days by a blinded central examiner. Favourable outcome is defined according to a sliding dichotomy where the definition of favourable outcome varies according to baseline severity. Severity will be defined according to the probability of poor outcome predicted by the IMPACT core model. A large battery of secondary outcomes including granular neuropsychological and quality of life measures will be performed. Ethics and dissemination: This has been approved by Advarra Ethics Committee (Pro00030585). Results will be presented at scientific meetings and published in peer-reviewed publications. Trial registration number: ClinicalTrials.gov Registry ( NCT03754114 ).

1 November 2016 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
JCJean-Marc Chauny
Jean-Marc Chauny
MMMartin Marquis
Martin Marquis
FBFrancis Bernard
Francis Bernard
DWDavid Williamson
David Williamson
MAMartin Albert
Martin Albert
RDRaoul Daoust
Raoul Daoust

25 November 2005 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
FBFrancis Bernard
Francis Bernard
JOJ. Outtrim
J. Outtrim
DMD. K. Menon
D. K. Menon
BMB. F. Matta
B. F. Matta
Background. Adrenal insufficiency impacts on the haemodynamic management of patients in intensive care. Very little is known about the incidence of adrenal insufficiency in the first 10 days after traumatic brain injury. Methods. We retrospectively reviewed the charts of 113 traumatic brain injury patients within 10 days of their injury. They all had a high-dose corticotropin stimulation test performed because of haemodynamic instability. Blood cortisol concentrations were measured at baseline, 30 and 60 min after the administration of high-dose corticotropin. The incidence of adrenal insufficiency was determined according to various definitions used in the literature. Results. The baseline cortisol concentration was <414 nmol litre−1 (15 μg dl−1) in 78% of patients and <690 nmol litre−1 (25 μg dl−1) in all patients. The cortisol concentration did not rise above 500 nmol litre−1 (18 μg dl−1) at 30 and 60 min in 49 and 22% of patients, respectively. The cortisol concentration did not rise by 250 nmol litre−1 (9 μg dl−1) at 30 and 60 min in 48 and 25% of patients respectively. Primary adrenal insufficiency defined by an abnormal baseline cortisol concentration and an abnormal response to the high-dose corticotropin stimulation test was present in 13–28% of patients according to the cut-off values used. Conclusions. The incidence of adrenal insufficiency varies from 25 to 100% in the first 10 days after traumatic brain injury. The range of incidences reported illustrates the need for standardization of the definition of adrenal insufficiency. This has a direct impact on treatment. Sampling at 60 min after the high-dose corticotropin stimulation test seems to correlate better with the maximum secreting capacity of the adrenal glands.

1 April 2008 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
FBFrancis Bernard
Francis Bernard
YAYahia Z. Al-Tamimi
Yahia Z. Al-Tamimi
DCDoris Bsc Chatfield
Doris Bsc Chatfield
ALAndy Lynch
Andy Lynch
BMBasil F. Frca Matta
Basil F. Frca Matta
DMDavid K. MD Menon
David K. MD Menon
Background: Serum albumin level is correlated with outcome in various clinical situations. Albumin has multiple physiologic properties that could be beneficial in brain injury. The Lund therapy for elevated intracranial pressure uses albumin as part of its protocol and demonstrates favorable outcome. We sought to find out if albumin is associated with outcome after traumatic brain injury to justify conducting a randomized trial. Methods: A retrospective study of traumatic brain injury patients was conducted. Characteristics known to influence outcome were included in a multiple logistic regression model to analyze predictors of poor outcome at 6 months. Results: Data were available for 138 patients. The majority of patients (65%) had a severe injury (Glasgow Coma Scale score <9). Seventy percent of patients had a favorable outcome. Albumin levels decrease considerably from normal values in the first few days after injury irrespective of outcome. Albumin remained <25 g/L for a longer period of time in patient with an unfavorable outcome (6 days vs. 3 days, p = 0.012). Multiple logistic regression analysis identified albumin levels, age, Glasgow Coma Scale score at admission, and Injury Severity Score as predictors of poor outcome. Conclusion: Serum albumin level seems to be an independent predictor of poor outcome. The model also identified classic predictors of poor outcome that tends to strengthen its adequacy. Because albumin level is the only modifiable factor influencing outcome, it seems justified to carry out a randomized trial of the use of albumin in the treatment of brain injury.

16 March 2016 in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Verified
Journal Article
Open access
PDF file
KSKarim Serri
Karim Serri
MRMalak El Rayes
Malak El Rayes
GGGeneviève Giraldeau
Geneviève Giraldeau
DWDavid Williamson
David Williamson
FBFrancis Bernard
Francis Bernard
Myocardial dysfunction has been well described with catastrophic neurological events, such as subarachnoid hemorrhage and brain death. There is very limited data describing myocardial function in the context of traumatic brain injury (TBI), as no prospective study has yet examined this association. The objective of our study was to evaluate cardiac function using echocardiography in patients with clinically important TBI. We conducted a prospective observational study of consecutive TBI patients admitted to the intensive care unit. All patients older than 16 years with moderate to severe TBI according to the Glascow Coma Scale (GCS) were eligible for the study. Only patients with a prior history of heart disease or cardiomyopathy or evidence of brain death on admission were excluded. A complete transthoracic echocardiogram was performed within 4 days of admission. Forty-nine patients (67 % males, median age 34 years) were included in the study. Forty-one patients had severe TBI (84 %) with a median GCS of six, 44 patients (90 %) required mechanical ventilation and 36 (74 %) intracranial pressure monitoring. Hospital mortality was 18 %. No patients had global left ventricular dysfunction as defined by a left ventricular ejection fraction (LVEF) below 50 % (95 % CI, 0–0.07). Average LVEF was 65 +/− 4 %. Four patients (8 %) had regional wall motion abnormalities with preserved LVEF. The main finding of this study is the absence of clinically significant myocardial dysfunction in patients with moderate or severe TBI. Although myocardial dysfunction has been well described in a variety of neurological settings, it is possible that the young age of TBI patients and the absence of cardiovascular risk factors are protective against significant myocardial injury from catecholamine excess. In a group of patients with clinically important TBI, we did not identify any significant cardiac dysfunction.

13 October 2022 in Critical Care Clinics
Verified
Journal Article
Closed access
FBFrancis Bernard
Francis Bernard